Navigation Links
AMT to Release Full Year 2007 Results on February 20, 2008
Date:2/12/2008

AMSTERDAM, February 12 /PRNewswire-FirstCall/ -- Amsterdam Molecular Therapeutics (Euronext: AMT), a leader in the field of human gene therapy, today announced that it will release its financial results for the full year 2007 on Wednesday, February 20, 2008 at 7:30 am Central European Time (CET). To discuss these results, the Company will conduct a conference call at 10 am CET. Netherlands Dial In: 0800-949-4517 (toll free); US Dial In: +1-866-291-4166 (toll free); UK Dial In: +44-207-107-0611. To listen to the conference call live via the internet, visit the investor relations portion of the AMT website at http://www.amtbiopharma.com. Please go to the website 15 minutes prior to the call to register, download and install the necessary audio software.

About Amsterdam Molecular Therapeutics

AMT has a unique gene therapy platform that to date appears to circumvent many if not all of the obstacles that have prevented gene therapy from becoming a mainstay of clinical medicine. Using adeno-associated viral (AAV) vectors as the delivery vehicle of choice for therapeutic genes, the company has been able to design and validate what is probably the first stable and scalable AAV GMP production platform. As such, AMT's proprietary platform holds tremendous promise for thousands of (rare) diseases that are caused by one faulty gene. AMT currently has a product pipeline with six products at different stages of development.


'/>"/>
SOURCE Amsterdam Molecular Therapeutics B.V
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1

Related biology technology :

1. ViroPharma to Release 2007 Fourth Quarter and Full Year Financial Results on February 27, 2008
2. 3SBio Inc. Schedules 2007 Fourth Quarter and Full Year Earnings Release on Wednesday, February 20, 2008
3. CellCyte Genetics Corp. Continues to Move Its Technology Forward in Light of Plaintiff Law Firm Press Releases
4. Intrasphere Technologies Releases PharmaCM Submissions Management and Authoring Module Powered by Microsoft Office SharePoint Server 2007
5. Correction to Press Release Dated January 31, 2008: Inverness Medical Innovations to Participate at 2008 Merrill Lynch Global Pharmaceutical, Biotechnology and Medical Device Conference on February 5, 2008
6. CryoLife Announces Release Date and Teleconference Call Details for the Fourth Quarter and Year End 2007 Financial Results
7. Techne Corporation Releases Unaudited Second Quarter Results for Fiscal Year 2008
8. Clontech Laboratories, Inc. Releases the ProteoTuner(TM) Systems
9. BioTrends Releases Fourth Annual Nephrology TreatmentTrends Publication Highlighting Market Trends for Renal Anemia, Hyperphosphatemia, and Secondary Hyperparathyroidism
10. ImaRx Therapeutics Receives Urokinase Lot Release Approval With Extended Expiration Dating
11. Hologic, Inc. to Release First Quarter Fiscal 2008 Operating Results Thursday, January 31st Before Market Opens
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/16/2009)... Martek Biosciences Corporation (Nasdaq: MATK ) ... and fiscal year ended October 31, 2009. Revenues for ... $90.4 million in the fourth quarter of fiscal 2008. ... share, for the fourth quarter of fiscal 2009, a ... diluted share, in last year,s fourth quarter. The ...
(Date:12/16/2009)... INDIANAPOLIS, Dec. 16 /PRNewswire/ -- ... Indiana,s life sciences industry and an active venture ... Company, Indiana State Teachers Retirement Fund, Indiana University, ... M. Fairbanks Foundation, and Credit Suisse today announced ... million venture capital fund of funds. ,, Organized ...
(Date:12/16/2009)... cell culture supplement? InVitria has what scientists have been asking ... that improves the growth and productivity of CHO cells. Developed ... an animal free, well defined and consistent recombinant CHO supplement. ... ... December 16, 2009 -- Scientists working with CHO cells can ...
(Date:12/15/2009)... Institute (JBEI), one of three Department of Energy (DOE) ... service to protect its valuable intellectual property. , ... ... December 15, 2009 -- Surety, LLC , the ... today announced that the Joint BioEnergy Institute (JBEI), one ...
Breaking Biology Technology:Martek Announces Fourth Quarter and FY 2009 Financial Results 2Martek Announces Fourth Quarter and FY 2009 Financial Results 3Martek Announces Fourth Quarter and FY 2009 Financial Results 4Martek Announces Fourth Quarter and FY 2009 Financial Results 5Martek Announces Fourth Quarter and FY 2009 Financial Results 6Martek Announces Fourth Quarter and FY 2009 Financial Results 7Martek Announces Fourth Quarter and FY 2009 Financial Results 8Martek Announces Fourth Quarter and FY 2009 Financial Results 9Martek Announces Fourth Quarter and FY 2009 Financial Results 10Martek Announces Fourth Quarter and FY 2009 Financial Results 11Martek Announces Fourth Quarter and FY 2009 Financial Results 12Martek Announces Fourth Quarter and FY 2009 Financial Results 13Martek Announces Fourth Quarter and FY 2009 Financial Results 14Indiana Industry, University and Community Leaders Capitalize on Next Generation of State's Life Sciences Growth 2Indiana Industry, University and Community Leaders Capitalize on Next Generation of State's Life Sciences Growth 3Indiana Industry, University and Community Leaders Capitalize on Next Generation of State's Life Sciences Growth 4Indiana Industry, University and Community Leaders Capitalize on Next Generation of State's Life Sciences Growth 5Online Video of InVitria's Zap-CHO Helps Scientists Maximize CHO Cell Culture Performance 2Joint BioEnergy Institute Selects Surety's AbsoluteProof to Protect the Integrity and Legally Defend the Authenticity of its Scientific Intellectual Property 2Joint BioEnergy Institute Selects Surety's AbsoluteProof to Protect the Integrity and Legally Defend the Authenticity of its Scientific Intellectual Property 3Joint BioEnergy Institute Selects Surety's AbsoluteProof to Protect the Integrity and Legally Defend the Authenticity of its Scientific Intellectual Property 4Joint BioEnergy Institute Selects Surety's AbsoluteProof to Protect the Integrity and Legally Defend the Authenticity of its Scientific Intellectual Property 5
... Aug. 5 Orexigen(R) Therapeutics,Inc. (Nasdaq: OREX ), ... system disorders, including obesity, will announce,financial results for its ... 2008, after the markets close. The announcement will be ... p.m. Pacific Time., Orexigen management will host the ...
... Innovations Inc.,(TSX: ATB), a recognized leading developer, manufacturer ... the health and,nutrition industries, today announced that its ... present a company overview,at the upcoming 28th Annual ... 2008 at 11 am (eastern time), in the ...
... NGSX ), a biopharmaceutical company focused on developing ... results for its second quarter 2008 on Wednesday, August ... to review the results will begin at 4:30 p.m. ... be hosted by Anthony DiTonno,President and Chief Executive Officer, ...
Other Biology Technology:Orexigen(R) Therapeutics Schedules Webcast Discussion of Financial Results for the Second Quarter Ended June 30, 2008 2NeurogesX to Report Second Quarter 2008 Financial Results 2NeurogesX to Report Second Quarter 2008 Financial Results 3
(Date:12/17/2009)... Mark December 10-13, 2010 on your calendar and ... the International Osteoporosis Foundation (IOF). , IOF has ... of Regional Programs that aims to create strong ... member associations. The overall Regional Program includes the ... pleased to announce that the first IOF Regional ...
(Date:12/17/2009)... showing that four commonly used chemotherapy drugs disrupt the ... could be partially reversed with the growth factor IGF-1. ... Cancer Investigation , the University of Rochester Medical Center ... who experience a frustrating decline in cognitive function after ... is not yet clear how our results can be ...
(Date:12/17/2009)... Department of Energy,s Savannah River National Laboratory (SRNL) ... SRNL,s unique Porous Walled Hollow Glass Microspheres available ... and other uses, including applications still being developed. ... years in light-weight filler material, insulation, abrasives and ... unique is the network of interconnected pores in ...
Breaking Biology News(10 mins):UR study reveals chemo's toxicity to brain, possible treatment 2UR study reveals chemo's toxicity to brain, possible treatment 3MO-SCI Corporation to manufacture, market SRNL's unique glass microspheres 2SenesTech Announces New Vice President of Business Development 12862 1SenesTech Announces New Vice President of Business Development 12862 2Virginia Mason Signs with Carefx to Implement Fusionfx Solution Suite 50490 1Virginia Mason Signs with Carefx to Implement Fusionfx Solution Suite 50490 2Virginia Mason Signs with Carefx to Implement Fusionfx Solution Suite 50490 3Fighting Multiple Sclerosis One Shirt at a Time 50485 1Fighting Multiple Sclerosis One Shirt at a Time 50485 2
... CAMBRIDGE, Mass. (March 26, 2009) The Howard Hughes ... an Early Career Scientist appointment, a six-year funded position ... , "I am thrilled to receive the HHMI Early ... remarkable history of supporting innovative and creative science, and ...
... MARCH 2009 More than 120 researchers will speak ... life sciences conference to be organized by the European ... 29 August to 1 September 2009. , The ... programmes reflecting the concepts and high-resolution approaches of modern ...
... is available in Spanish . , ... of psychosis and schizophrenia, and those episodes of psychosis ... characteristics, both before their appearance and in the clinical ... conclusions of the doctoral thesis "Neurodevelopment and environmental stress ...
Other Biology News:Whitehead member Peter Reddien named HHMI Early Career Scientist 2Call for abstracts and registration for the EMBO Meeting 2009 2Daily consumption of cannabis predisposes to the appearance of psychosis and schizophrenia 2
Carrier Serum...
A robust formulation of Taq Polymerase supplied with a 10X colored reaction buffer which allows Direct Gel-Loading...
...
Borrelia Burgdorfen (IgG) -Ab EIA Sample Size: 100 l...
Biology Products: